Bailey Echols, AMC21 awardee mentored by Eason Hildreth, has been accepted to the CCTS Predoctoral Clinical/Translational Research Program (T32). His project centers around the role of the transcription factor PU.1 in renal cell carcinoma progression. His two-year appointment will begin on July 1, 2025.